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A 43-year-old lady with nasopharyngeal carcinoma was
treated with neoadjuvant chemotherapy, consisting of
cisplatin and 5-fluorouracil. Pretreatment serum cre-
atinine was 59 μmol/L. On day 12 of chemotherapy,
she was found to be hypotensive and anuric. Renal
function tests showed serum potassium levels of
5.8 mmol/L, urea of 22.5 mmol/L, and creatinine of
474 μmol/L. Renal biopsy showed swelling and fine
vacuolation of the proximal tubular cells, whereas the
distal tubular cells showed regenerative changes (Panel
A). The interstitium showed focal and sparse infiltrate
of lymphocytes and few plasma cells. There was mini-
mal tubular atrophy and interstitial fibrosis. The via-
ble glomeruli and the vessels appeared unremarkable
(Panel B). Her renal function recovered spontaneous-
ly after 1 week of hemodialysis.
Cisplatin is an alkylating agent and has been used
in the treatment of various solid tumors. Nephrotoxici-
ty is one of its major dose-limiting adverse effects,
especially when hydration is inadequate. In our patient,
dehydration due to severe mucositis predisposed her to
cisplatin nephrotoxicity. Cisplatin is preferentially
absorbed by proximal tubular cells, which explains the
predominant site of renal injury in this particular area.
The histologic features of cisplatin nephrotoxicity
mimics those of osmotic nephrosis, which are mostly
reported in patients receiving hyperosmolar fluids such
as iodinated contrast media, mannitol, plasma ex-
panders containing hydroxyethyl starch, and intra-
venous immunoglobulin infusion.
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